Partnering with Qualicaps

Qualicaps continues to provide a trusted delivery vehicle for pharmaceutical and nutritional products.

Inhalation delivery offers significant and unique benefits in the treatment of a variety of illnesses. The lungs serve as a portal of entry to the body that enables a drug to infiltrate the bloodstream from the airways in a time-effective manner, thus presenting inhaled formulations as an interesting alternative to oral dosage forms, especially when a rapid response is required. Originally developed for respiratory diseases, DPIs have seen their use expanded recently to a growing field of therapies, including antibiotics, insulin, opioids, oxytocin, vaccines, and drugs for neurological disorders.

Solid oral dosage forms (tablets and capsules, both hard and soft) are the most popular delivery option among patients, doctors and pharmaceutical companies. They are “patient-friendly”: readily portable, convenient to auto-administer, easy to swallow, stable and precise in delivering the active ingredient. Hard two-piece capsules also offer additional advantages over tablets, among others: less complex formulations, using less excipients, possibility of combining drug products , more appropriate for hygroscopic active ingredients, option of using two colors (for the capsule cap and body) for product marketing, more efficient product manufacturing process (reduced amount of steps),reducing validation and analytical costs, as well as absence of compression forces in product manufacturing.